EPS for Apollo Endosurgery, Inc. (APEN) Expected At $-0.33

February 19, 2018 - By Hazel Jackson

 EPS for Apollo Endosurgery, Inc. (APEN) Expected At $ 0.33

Analysts expect Apollo Endosurgery, Inc. (NASDAQ:APEN) to report $-0.33 EPS on March, 14.They anticipate $34.68 EPS change or 99.06 % from last quarter’s $-35.01 EPS. After having $-0.32 EPS previously, Apollo Endosurgery, Inc.’s analysts see 3.13 % EPS growth. The stock decreased 0.47% or $0.03 during the last trading session, reaching $6.4. About 18,052 shares traded. Apollo Endosurgery, Inc. (NASDAQ:APEN) has declined 51.87% since February 20, 2017 and is downtrending. It has underperformed by 68.57% the S&P500.

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for the treatment of obesity. The company has market cap of $110.66 million. The firm offers endo-bariatric products, such as Orbera intragastric balloon system, a non-surgical alternative for the treatment of overweight and obese adults; and OverStitch, an endoscopic suturing system that enables endoscopic procedures by allowing physicians to place full-thickness sutures and secure the approximation of tissue through an Olympus dual-channel flexible endoscope. It currently has negative earnings. It also provides surgical products, including Lap-Band system, a system designed to provide minimally invasive long-term treatment of obesity; and accessories used in laparoscopic bariatric surgeries.

More notable recent Apollo Endosurgery, Inc. (NASDAQ:APEN) news were published by: Businesswire.com which released: “Apollo Endosurgery, Inc. Reports Second Quarter 2017 Results” on August 01, 2017, also Quotes.Wsj.com with their article: “News Apollo Endosurgery Inc.APEN” published on December 30, 2016, Prnewswire.com published: “Apollo Endosurgery and Lpath Sign Merger Agreement” on September 08, 2016. More interesting news about Apollo Endosurgery, Inc. (NASDAQ:APEN) were released by: Businesswire.com and their article: “Apollo Endosurgery Receives FDA Clearance for OverStitchâ„¢ Sx Endoscopic …” published on November 27, 2017 as well as Businesswire.com‘s news article titled: “Apollo Endosurgery, Inc. Announces Pricing of $31 Million Public Offering” with publication date: July 20, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.